Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review

  • ID: 4391494
  • SWOT Analysis
  • Region: India
  • 45 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Atul Ltd
  • BASF India Ltd
  • Divi's Laboratories Ltd
  • Hikal Ltd
  • Suven Life Sciences Ltd
  • MORE
Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol. It has premier facilities for the manufacture of APIs, PFIs and FDs. With offices in India, the US, the UK, China and Colombia, the company offers products and solutions to companies across the world. Granules also provides contract research and manufacturing services. Its key clients include leading generic and branded pharmaceutical companies. Granules is headquartered in Hyderabad, Telangana, India.

Granules India Ltd Key Recent Developments

May 24, 2018: Granules India’s Total Income increases by 18% to INR 1,703 Cr
Mar 26, 2018: Granules India's Gagillapur and Jeedimetla facilities complete US FDA inspection
Feb 28, 2018: Granules India’s Chantilly facility received EIR from USFDA
Feb 08, 2018: Granules India's Revenue from operation increases by 14% to INR 411 Cr
Nov 09, 2017: Granules India’s Revenue from operation increases by 8% to INR 393 Cr

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Atul Ltd
  • BASF India Ltd
  • Divi's Laboratories Ltd
  • Hikal Ltd
  • Suven Life Sciences Ltd
  • MORE
Section 1 - About the Company

Granules India Ltd - Key Facts
Granules India Ltd - Key Employees
Granules India Ltd - Key Employee Biographies
Granules India Ltd - Major Products and Services
Granules India Ltd - History
Granules India Ltd - Company Statement
Granules India Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

Section 2 - Company Analysis

Company Overview
Granules India Ltd - Business Description
Granules India Ltd - SWOT Analysis
SWOT Analysis - Overview
Granules India Ltd - Strengths
Granules India Ltd - Weaknesses
Granules India Ltd - Opportunities
Granules India Ltd - Threats
Granules India Ltd - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Granules India Ltd, Recent Deals Summary

Section 5 - Company’s Recent Developments

May 24, 2018: Granules India’s Total Income increases by 18% to INR 1,703 Cr
Mar 26, 2018: Granules India's Gagillapur and Jeedimetla facilities complete US FDA inspection
Feb 28, 2018: Granules India’s Chantilly facility received EIR from USFDA
Feb 08, 2018: Granules India's Revenue from operation increases by 14% to INR 411 Cr
Nov 09, 2017: Granules India’s Revenue from operation increases by 8% to INR 393 Cr
Oct 06, 2017: Receipt of establishment report by Granules OmniChem facility from US FDA
Aug 16, 2017: Granules India Reports Establishment Inspection Report (EIR) From US FDA-Reg.
Aug 14, 2017: Granules India Reported Its First Quarter Financial Results 2017
May 11, 2017: Granules India’s Revenue increases 4% to Rs. 1,435 Cr.; Net Profit surges 34% to Rs. 165 Cr
Feb 03, 2017: Granules India’s Gagillapur facility completed INFARMED reinspection

Section 6 - Appendix

Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables

Granules India Ltd, Key Facts
Granules India Ltd, Key Employees
Granules India Ltd, Key Employee Biographies
Granules India Ltd, Major Products and Services
Granules India Ltd, History
Granules India Ltd, Subsidiaries
Granules India Ltd, Joint Venture
Granules India Ltd, Key Competitors
Granules India Ltd, Ratios based on current share price
Granules India Ltd, Annual Ratios
Granules India Ltd, Annual Ratios (Cont...1)
Granules India Ltd, Annual Ratios (Cont...2)
Granules India Ltd, Interim Ratios
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Granules India Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Granules India Ltd, Performance Chart (2014 - 2018)
Granules India Ltd, Ratio Charts
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Granules India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Aditya Birla Chemicals (India) Ltd
  • Atul Ltd
  • BASF India Ltd
  • Divi's Laboratories Ltd
  • Hikal Ltd
  • Ind-Swift Laboratories Ltd
  • Suven Life Sciences Ltd
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll